EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles

Selene Seoyun Lee iD, Livia Civitelli iD, Laura Parkkinen iD

eLife · 25.11.2024 · 13

DOI: 10.7554/elife.92775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 25.11.2024. Verfasst von Selene Seoyun Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Center, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: alpha-Synuclein, Brain, Parkinson Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oxford-GSK Institute of Molecular and Computational Medicine, NIHR Oxford Biomedical Research Centre, Parkinson's Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The alpha-synuclein (αSyn) seeding amplification assay (SAA) that allows the generation of disease-specific in vitro seeded fibrils (SAA fibrils) is used as a research tool to study the connection between the structure of αSyn fibrils, cellular seeding/spreading, and the clinicopathological manifestations of different synucleinopathies. However, structural differences between human brain-derived and SAA αSyn fibrils have been recently highlighted. Here, we characterize the biophysical properties of the human brain-derived αSyn fibrils from the brains of patients with Parkinson’s disease with and without dementia (PD, PDD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and compare them to the ‘model’ SAA fibrils. We report that the brain-derived αSyn fibrils show distinct biochemical profiles, which were not replicated in the corresponding SAA fibrils. Furthermore, the brain-derived αSyn fibrils from all synucleinopathies displayed a mixture of ‘straight’ and ‘twisted’ microscopic structures. However, the PD, PDD, and DLB SAA fibrils had a ’straight’ structure, whereas MSA SAA fibrils showed a ‘twisted’ structure. Finally, the brain-derived αSyn fibrils from all four synucleinopathies were phosphorylated (S129). Interestingly, phosphorylated αSyn were carried over to the PDD and DLB SAA fibrils. Our findings demonstrate the limitation of the SAA fibrils modeling the brain-derived αSyn fibrils and pay attention to the necessity of deepening the understanding of the SAA fibrillation methodology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinBrainParkinson DiseaseHumansSynucleinopathiesAgedFemaleMaleLewy Body DiseaseMultiple System Atrophy

Stichwörter der Autor:innen

Alpha-synucleinSynucleinopathieshumanneuroscienceseeded amplification assaystrains

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Center, University of Oxford, Oxford, United Kingdom.

ORCID-Profile: Selene Seoyun Lee, Livia Civitelli, Laura Parkkinen

Förderung

  • Oxford-GSK Institute of Molecular and Computational Medicine
  • NIHR Oxford Biomedical Research Centre
  • Parkinson's Foundation
  • Michael J Fox Foundation for Parkinson's Disease Research
  • Galen and Hilary Weston Foundation
  • National Institutes of Health

Zitieren

APA

Lee, S. S., Civitelli, L., & Parkkinen, L. (2024). Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles. eLife, 13. https://doi.org/10.7554/elife.92775

Vancouver

Lee SS, Civitelli L, Parkkinen L. Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles. eLife. 2024;13. doi:10.7554/elife.92775

BibTeX
@article{Lee2024,
  author = {Lee, Selene Seoyun and Civitelli, Livia and Parkkinen, Laura},
  title = {Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.92775}
}
Kostenlos starten →